Stay updated on M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s displayed software/version label is updated from v3.5.2 to v3.5.3, reflecting a maintenance or release revision without changing the study record details.
    Difference
    0.1%
    Check dated 2026-04-24T06:18:23.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:28.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T08:36:39.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 in the history. No substantive content changes are evident from the screenshots.
    Difference
    0.1%
    Check dated 2026-03-12T02:49:59.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history; older notices (v3.4.1 and a government funding banner) were removed. These updates affect the UI/site banners rather than the clinical trial content.
    Difference
    0.5%
    Check dated 2026-02-11T12:00:37.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    A system-wide funding notice was added to the page and the revision version updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:32:20.000Z thumbnail image

Stay in the know with updates to M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.